Cerdelga (Genzyme Corporation)
Welcome to the PulseAid listing for the Cerdelga drug offered from Genzyme Corporation. This Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genzyme Corporation |
| NON-PROPRIETARY NAME: | eliglustat |
| SUBSTANCE NAME: | ELIGLUSTAT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-09-03 |
| END MARKETING DATE: | 0000-00-00 |
Cerdelga HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cerdelga from Genzyme Corporation |
| LABELER NAME: | Genzyme Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 84(mg/1) |
| START MARKETING DATE: | 2014-09-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58468-0220_7887c191-03db-4a18-9dea-b3907d0e9856 |
| PRODUCT NDC: | 58468-0220 |
| APPLICATION NUMBER: | NDA205494 |
Other ELIGLUSTAT Pharmaceutical Manufacturers / Labelers:
